BridgeMD
New treatment option for Racism
Official title The Impact of a Race-Based Stress Reduction Intervention
ClinicalTrials.gov ID: NCT05902741
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether a stress reduction program called Resilience, Stress, and Ethnicity (RiSE) improves well-being, inflammation, and the epigenome in African American (AA) women who have risk factors for heart or metabolic disease. The main question it aims to answer is whether an intervention that integrates cognitive-behavioral strategies focused on the impact that social stress, such as racism, has on the body, racial identity development, and empowerment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 75, women only
You may be able to join if
- Between the ages of 50 and 75
- Female
- Post-menopausal (without menstrual period for at least 12 consecutive months)
- Self-identified AA or Black
- Able to write, read, speak English
You likely can't join if
- History of myocardial infarction or ischemic heart disease/angina, stent placement, coronary artery bypass, left ventricular hypertrophy, congestive...
- Any major immune-related disease (e.g., rheumatoid arthritis. lupus)
- Use of immune-altering medications, such as glucocorticoids
- Periodontal disease, bleeding gums, dental work in past 72 hours
- Current smoker or has smoked in past 3 months
- Active cancer
See the full eligibility criteria
- Between the ages of 50 and 75
- Female
- Post-menopausal (without menstrual period for at least 12 consecutive months)
- Self-identified AA or Black
- Able to write, read, speak English
- Must have at least 1 of any of the following:
- Waist circumference \>88 cm
- Systolic BP\>130 mmHg and/ or diastolic BP\>88 mmHg or on antihypertensive medications
- Diagnosed and/or being treated for hypercholesterolemia
- History of Type 2 diabetes
- History of myocardial infarction or ischemic heart disease/angina, stent placement, coronary artery bypass, left ventricular hypertrophy, congestive heart failure, or ischemic stroke
- Any major immune-related disease (e.g., rheumatoid arthritis. lupus)
- Use of immune-altering medications, such as glucocorticoids
- Periodontal disease, bleeding gums, dental work in past 72 hours
- Current smoker or has smoked in past 3 months
- Active cancer
- Active infection
- Substance abuse
- Cognitive or psychiatric disorder that would affect ability to participate in classes (Brief Screen for Cognitive Impairment total score of 8 or higher)
The study team makes the final eligibility decision.
Where it's taking place
- Maywood, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 50 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maywood, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.